Read + Share
Samlowski W, Adajar C. Cautious addition of targeted therapy to PD-1 inhibitors after initial
progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy. BMC Cancer 2021;21:1187.
PMID: 34743688
|
 |
|
Samlowski W, Adajar C. Cautious addition of targeted therapy to PD-1 inhibitors after initial
progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy. BMC Cancer 2021;21:1187.
PMID: 34743688
|
|
|
|